V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20160272 | 20061729 | 1.7 | 58.7 | Adjuvant (A) | 2019-09-13 | 2019-09-16 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101659746 |
| 20160273 | 20061730 | 1.66 | 122 | null | 2017-05-19 | 2017-06-02 | CAPECITABINE + GEMCITABINE | 02 | Y | CAPECITABINE + GEMCITABINE | 100701514 |
| 20160276 | 20061731 | 1.55 | 91.8 | null | 2016-04-09 | 2016-04-23 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100504082 |
| 20160277 | 20061732 | null | 91 | Neo-adjuvant (N) | 2017-03-20 | 2017-03-29 | ECX | null | N | ECX | 101221426 |
| 20160278 | 20061733 | 1.7 | 95.6 | null | 2018-03-23 | 2018-04-11 | ECX | N | N | ECX | 101092130 |
| 20160279 | 20061734 | 1.64 | 76.2 | Neo-adjuvant (N) | 2017-01-04 | 2017-01-04 | ECX | 2 | N | ECX | 101521212 |
| 20160280 | 20061735 | 1.64 | 97.45 | Neo-adjuvant (N) | 2016-08-09 | 2016-08-31 | ECX | N | N | ECX | 101170055 |
| 20160281 | 20061736 | 1.76 | 82.8 | Neo-adjuvant (N) | 2019-02-06 | 2019-02-11 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101026059 |
| 20160282 | 20061737 | 1.63 | 80.9 | Neo-adjuvant (N) | 2017-12-15 | 2017-12-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101661976 |
| 20160283 | 20061738 | 1.7 | 77.3 | Neo-adjuvant (N) | 2017-09-28 | 2017-10-10 | ECX | 02 | N | ECX | 101350512 |
| 20160286 | 20061739 | 1.65 | 69.8 | Neo-adjuvant (N) | 2018-01-12 | 2018-01-22 | ECX | N | N | ECX | 100422215 |
| 20160289 | 20061740 | 1.72 | 107 | Palliative (P) | 2018-09-06 | 2018-09-11 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101010540 |
| 20160290 | 20061741 | 1.45 | 66.9 | Adjuvant (A) | 2017-06-02 | 2017-06-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101062900 |
| 20160291 | 20061742 | 1.64 | 103.25 | Neo-adjuvant (N) | 2016-04-20 | 2016-04-25 | ECX | N | N | ECX | 100631956 |
| 20160292 | 20061743 | 1.69 | 46.2 | Neo-adjuvant (N) | 2017-06-14 | 2017-06-27 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101826170 |
| 20160294 | 20061744 | 1.8 | 78.4 | Neo-adjuvant (N) | 2019-07-12 | 2019-08-10 | ECX | N | N | ECX | 101120115 |
| 20160296 | 20061745 | 1.79 | 72.8 | Palliative (P) | 2019-10-12 | 2019-10-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101266373 |
| 20160297 | 20061746 | 1.73 | 71 | Neo-adjuvant (N) | null | 2019-11-23 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101254878 |
| 20160298 | 20061747 | 1.53 | 62.3 | Palliative (P) | 2018-10-19 | 2018-10-19 | ECX | N | null | ECX | 100253290 |
| 20160300 | 20061748 | 1.62 | null | Palliative (P) | 2017-09-20 | 2017-10-04 | ECX | N | N | ECX | 100476647 |
| 20160301 | 20061749 | 1.58 | 54.3 | Neo-adjuvant (N) | null | 2019-01-08 | ECX | null | N | ECX | 100166385 |
| 20160303 | 20061750 | 1.71 | 58 | Neo-adjuvant (N) | 2016-08-19 | 2016-08-22 | ECX | 2 | N | ECX | 101299854 |
| 20160304 | 20061751 | null | null | Adjuvant (A) | 2017-06-04 | 2017-06-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100532727 |
| 20160305 | 20061752 | 1.66 | 81.5 | Neo-adjuvant (N) | 2019-08-12 | 2019-08-23 | ECX | N | N | ECX | 101130125 |
| 20160307 | 20061753 | 1.7 | 51.7 | Neo-adjuvant (N) | 2019-04-17 | 2019-05-01 | ECX | N | N | ECX | 100089071 |
| 20160309 | 20061754 | 1.67 | 75.6 | Adjuvant (A) | 2017-07-11 | 2017-07-19 | CAPECITABINE + GEMCITABINE | 02 | Y | CAPECITABINE + GEMCITABINE | 100830752 |
| 20160310 | 20061755 | 1.7 | 84 | Curative (C) | 2019-11-26 | 2019-12-23 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101453123 |
| 20160311 | 20061756 | 1.68 | 64 | null | 2017-01-09 | 2017-01-13 | ECX | N | N | ECX | 100552872 |
| 20160314 | 20061757 | 1.58 | 67.1 | Neo-adjuvant (N) | 2016-12-24 | 2017-01-21 | ECX | 02 | N | ECX | 100967163 |
| 20160316 | 20061758 | 1.53 | 53.65 | Neo-adjuvant (N) | 2019-06-01 | 2019-06-01 | ECX | 02 | N | ECX | 101466003 |
| 20160319 | 20061759 | 1.76 | 73.6 | Palliative (P) | 2019-11-21 | 2019-11-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101835647 |
| 20160320 | 20061760 | 1.66 | 56.2 | Adjuvant (A) | 2019-11-15 | 2019-11-15 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100372416 |
| 20160321 | 20061761 | 1.65 | 83.6 | null | 2018-11-01 | 2018-11-08 | ECX | 2 | N | CAPECITABINE + GEMCITABINE | 101866424 |
| 20160322 | 20061762 | 1.75 | 79.1 | Adjuvant (A) | 2016-12-29 | 2016-12-31 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101088920 |
| 20160323 | 20061763 | 1.54 | 81.1 | Neo-adjuvant (N) | 2018-04-17 | 2018-05-08 | ECX | N | N | ECX | 100341152 |
| 20160324 | 20061764 | 1.66 | 101.2 | Adjuvant (A) | 2019-07-22 | 2019-08-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101235682 |
| 20160329 | 20061765 | 1.76 | 82.9 | Palliative (P) | 2019-07-01 | 2019-07-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100182356 |
| 20160330 | 20061766 | 1.59 | 74.6 | Neo-adjuvant (N) | 2017-09-10 | 2017-09-28 | ECX | 2 | null | ECX | 101161061 |
| 20160331 | 20061767 | 1.58 | 70 | Palliative (P) | 2018-11-20 | 2018-11-20 | ECX | 02 | N | ECX | 101050616 |
| 20160333 | 20061768 | 1.85 | 93 | Palliative (P) | 2019-11-05 | 2019-11-09 | ECX | N | N | ECX | 101185467 |
| 20160335 | 20061769 | 1.74 | 71 | Palliative (P) | null | 2019-01-15 | CAPECITABINE + GEMCITABINE | 99 | N | CAPECITABINE + GEMCITABINE | 101359645 |
| 20160336 | 20061770 | 1.68 | 90.5 | Neo-adjuvant (N) | 2019-12-31 | 2020-01-06 | ECX | 1 | N | ECX | 101634620 |
| 20160338 | 20061771 | 1.8 | 120 | null | 2016-04-20 | 2016-05-11 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100126202 |
| 20160342 | 20061772 | 1.65 | null | Neo-adjuvant (N) | 2016-08-16 | 2016-08-24 | ECX | N | N | ECX | 100762825 |
| 20160344 | 20061773 | 1.51 | 75.3 | Neo-adjuvant (N) | 2019-12-02 | 2019-12-09 | Gemcitabine + Capecitabine | N | N | ECX | 101600517 |
| 20160345 | 20061774 | 1.87 | 67 | Neo-adjuvant (N) | 2016-03-31 | 2016-04-10 | ECX | N | N | ECX | 100414255 |
| 20160346 | 20061775 | 1.75 | 71.5 | Neo-adjuvant (N) | 2018-11-09 | 2018-11-23 | ECX | N | N | ECX | 100999883 |
| 20160348 | 20061776 | 1.79 | 79.4 | Neo-adjuvant (N) | 2019-08-26 | 2019-09-05 | ECX | N | N | ECX | 101384622 |
| 20160349 | 20061777 | 1.6 | 71 | Palliative (P) | 2017-08-03 | 2017-08-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101807230 |
| 20160352 | 20061778 | 1.72 | 75 | Neo-adjuvant (N) | 2016-02-08 | 2016-02-14 | ECX | 2 | N | ECX | 101412883 |